WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 522503
Description: A‑971432 is a potent, orally bioavailable, selective Sphingosine-1-Phosphate Receptor 5 (S1P5) agonist for the potential treatment of neurodegenerative disorders. A‑971432 is highly selective for S1P5 and has excellent plasma and CNS exposure after oral dosing in preclinical species. A‑971432 improves blood−brain barrier integrity in an in vitro model and reverses age-related cognitive decline in mice. S1P5 agonism is an innovative approach with potentialbenefit in neurodegenerative disorders involving lipid imbalance and/or compromised blood−brain barrier such as Alzheimer’s disease or multiple sclerosis.
MedKoo Cat#: 522503
Chemical Formula: C18H17Cl2NO3
Exact Mass: 365.05855
Molecular Weight: 366.238
Elemental Analysis: C, 59.03; H, 4.68; Cl, 19.36; N, 3.82; O, 13.11
A‑971432 is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to email@example.com to inquire quote.
Synonym: A‑971432; A 971432; A971432.
IUPAC/Chemical Name: 1-(4-((3,4-Dichlorobenzyl)oxy)benzyl)azetidine-3-carboxylic Acid
InChi Key: WAAWETUDFSIYSD-UHFFFAOYSA-N
InChi Code: InChI=1S/C18H17Cl2NO3/c19-16-6-3-13(7-17(16)20)11-24-15-4-1-12(2-5-15)8-21-9-14(10-21)18(22)23/h1-7,14H,8-11H2,(H,22,23)
SMILES Code: O=C(C1CN(CC2=CC=C(OCC3=CC=C(Cl)C(Cl)=C3)C=C2)C1)O
The following data is based on the product molecular weight 366.238 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Hobson AD, Harris CM, van der Kam E, Turner SC, Abibi A, Aguirre AL, Bousquet P, Kebede T, Konopacki DB, Gintant G, Kim Y, Larson K, Maull J, Moore NS, Shi D, Shrestha A, Tang X, Zhang P, Sarris KK. Discovery of A-971432, an Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonists for the Potential Treatment of Neurodegenerative Disorders. J Med Chem. 2015 Oct 28. [Epub ahead of print] PubMed PMID: 26509640.